Cargando…
Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
BACKGROUND: Some patients with depression do not respond to first and second line conventional antidepressants and are therefore characterised as suffering from treatment refractory depression (TRD). On-going psychosocial stress and dysfunction of the hypothalamic-pituitary-adrenal axis are both ass...
Autores principales: | McAllister-Williams, R Hamish, Smith, Eleanor, Anderson, Ian M, Barnes, Jane, Gallagher, Peter, Grunze, Heinz CR, Haddad, Peter M, House, Allan O, Hughes, Tom, Lloyd, Adrian J, McColl, Elaine MM, Pearce, Simon HS, Siddiqi, Najma, Sinha, Baxi, Speed, Chris, Steen, I Nick, Wainright, June, Watson, Stuart, Winter, Fiona H, Ferrier, I Nicol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750720/ https://www.ncbi.nlm.nih.gov/pubmed/23914988 http://dx.doi.org/10.1186/1471-244X-13-205 |
Ejemplares similares
-
Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake
por: McNelis, Joanne C., et al.
Publicado: (2013) -
The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression
por: Strawbridge, Rebecca, et al.
Publicado: (2021) -
Antiglucocorticoid RU38486 reduces net protein catabolism in experimental acute renal failure
por: Mondry, Adrian
Publicado: (2005) -
Cognitive function after electroconvulsive therapy for depression: relationship to clinical response
por: Anderson, Ian M., et al.
Publicado: (2021) -
Autonomic dysregulation, cognition and fatigue in people with depression and in active and healthy controls: observational cohort study
por: Costa, Tiago, et al.
Publicado: (2023)